Novel approaches to characterize depressive symptoms and cognitive outcomes
Novel approaches to characterize depressive symptoms and cognitive outcomes
批准号:
8721662
负责人:
ALISON G ABRAHAM
金额:
$8.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-15 至 2016-04-30
关键词:
Acquired Immunodeficiency SyndromeAgeAgingAreaBehaviorBehavioralBiologicalBone DiseasesCD4 Lymphocyte CountCardiovascular DiseasesChronicCognitiveCohort StudiesComplexDataData SourcesDevelopmentDiseaseEpidemiologic MethodsFundingGaysGoalsHIVHIV InfectionsHealthHighly Active Antiretroviral TherapyHomophobiaImpaired cognitionImpairmentIndividualInfectionInterventionKidney DiseasesLife Cycle StagesMalignant NeoplasmsMemoryMental DepressionMental HealthMetabolic DiseasesMethodsModelingNatureNeurocognitiveOutcomePathway interactionsPatternPerformancePersonsPopulationPrevalencePsyche structurePsychosocial FactorQuality of lifeRaceRecording of previous eventsResearchRiskRoleSecondary toSeveritiesSocial supportSubstance abuse problemTestingTimeUnited States National Institutes of HealthVictimizationViral Load resultWorkage relatedantiretroviral therapycenter for epidemiological studies depression scalecognitive functiondepressive symptomsexecutive functionflexibilityhigh riskimprovedintervention programmenmen who have sex with menneuropsychologicalnovelnovel strategiespreventprocessing speedpsychosocialpublic health relevancescreeningsocialsocial stressstressortrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As we shift HIV-research focus towards secondary complications and aging in the modern therapy era, mental, behavior and cognitive health are critical domains for study. HIV-infected individuals are at high risk for depression, substance abuse and cognitive impairments, all of which can be exacerbated by the social stresses that gay and HIV-infected populations often endure. Many of these problems are also problems of aging and the U.S. HIV-infected population is rapidly approaching a median age of 50 years. These issues can only rise in importance as age and HIV-related factors drive up the prevalence of depression and cognitive impairment. We propose to use a comprehensive approach to understand the complex relationships between psychosocial factors and long term trends in depression and cognitive function. Using novel statistical approaches and data from the Multicenter AIDS Cohort Study, a well-described data source with many under- utilized psychosocial variables and over 25 years of under-explored depressive symptom and neuropsychological (NP) function history, we will elucidate the pathways leading from life-course social stressors through depression to NP decline by: 1. Elucidating the longitudinal relationship between depressive symptoms and NP function tests/self- perceived memory among HIV-infected men. 2. Examining complex interrelations between NP function tests/self-perceived memory, depressive symptoms, substance abuse, social stressors (internalized homophobia, gay victimization), social support and connectedness, HIV disease indicators (viral load, CD4 cell count) and race. 3. Developing methods for identifying and characterizing distinctive patterns of longitudinal depressive symptom and NP outcome data in HIV-infected and -uninfected men who have sex with men (MSM) and describe how treated HIV infection influences these trajectories. Depression is a treatable condition. Disrupting a long-term pattern
of chronic or cyclic depression may provide more than just improved quality of life; such an intervention may also prevent, halt or even reverse cognitive function decline. Understanding the nature of the relationship and the myriad pathways between an HIV-infected person's history of depression and their NP functional trajectory is an important first step towards devising an effective screening and intervention program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eye Determinants of Cognition (EyeDOC) Study
-
批准号:9175612
-
项目类别:
-
资助金额:$72.87万
-
财政年份:2016
-
负责人:ALISON G ABRAHAM
-
依托单位:
Eye Determinants of Cognition (EyeDOC) Study
-
批准号:9345988
-
项目类别:
-
资助金额:$71.12万
-
财政年份:2016
-
负责人:ALISON G ABRAHAM
-
依托单位:
Novel approaches to characterize depressive symptoms and cognitive outcomes
-
批准号:8848143
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2014
-
负责人:ALISON G ABRAHAM
-
依托单位:
Novel approaches to characterize depressive symptoms and cognitive outcomes
-
批准号:9260137
-
项目类别:
-
资助金额:$1.06万
-
财政年份:2014
-
负责人:ALISON G ABRAHAM
-
依托单位:
Vitamin D Deficiency, Inflammation and Age-related disease in HIV-Infected Men
-
批准号:8645957
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2013
-
负责人:ALISON G ABRAHAM
-
依托单位:
Biostatistics Module
-
批准号:10700922
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1997
-
负责人:ALISON G ABRAHAM
-
依托单位:
Biostatistics Module
-
批准号:10256786
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1997
-
负责人:ALISON G ABRAHAM
-
依托单位:
Biostatistics Module
-
批准号:10020644
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1997
-
负责人:ALISON G ABRAHAM
-
依托单位:
Biostatistics Module
-
批准号:9795548
-
项目类别:
-
资助金额:$22.11万
-
财政年份:--
-
负责人:ALISON G ABRAHAM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: